Publications

  1. Houghton DE, Ashrani A, Liedl D, Mehta RA, Hodge DO, Rooke T, Wennberg P, Wysokinski W, McBane R. Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study. Blood. 2021 Jun 10; 137 (23):3284-3290
    View PubMed
  2. MacArthur TA, Spears GM, Kozar RA, Dong JF, Auton M, Jenkins DH, Bailey KR, Ashrani AA, Ferrara MJ, Immermann JM, Halling TM, Park MS. Thrombin Generation Kinetics are Predictive of Rapid Transfusion in Trauma Patients Meeting Critical Administration Threshold. Shock. 2021 Mar 1; 55 (3):321-325
    View PubMed
  3. Smith CJ, Kluck LA, Ruan GJ, Ashrani AA, Marshall AL, Pruthi RK, Shah MV, Wolanskyj-Spinner A, Gangat N, Litzow MR, Hogan WJ, Sridharan M, Go RS. Leukocytosis and Tobacco Use: An Observational Study of Asymptomatic Leukocytosis. Am J Med. 2021 Jan; 134 (1):e31-e35 Epub 2020 July 16
    View PubMed
  4. Saadalla A, Seheult J, Ladwig P, Tange J, Leger R, Kohlhagen M, Ashrani A, Murray D. Sialic acid-bearing paraproteins are implicated in heparin-like coagulopathy in patients with myeloma. Blood 2020 Oct 22; 136 (17):1988-1992
    View PubMed
  5. Seheult JN, Cardel L, Tange JI, Ashrani A, Nichols WL, Heikal N, Chen D. An In Silico Exploration of the Factors That Affect the Precision of the Bethesda Assay. Am J Clin Pathol. 2020 Oct 13; 154 (5):671-682
    View PubMed
  6. Bubik RJ, Barth DM, Hook C, Wolf RC, Muth JM, Mara K, Patnaik MS, Pruthi RK, Marshall AL, Litzow MR, Elliott MA, Hogan WJ, Shah MV, Begna KH, Alkhateeb H, Pardanani A, Ashrani AA, Call TG, Rivera CE, Camoriano JK, Go RS, Wolanskyj-Spinner AP, Parikh SA. Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis. Leuk Lymphoma. 2020 Jul; 61 (7):1592-1600 Epub 2020 Mar 11
    View PubMed
  7. Azer SM, Eckerman AL, Rodriguez V, Nichols WL Jr, Ashrani AA, Hook CC, Marshall AL, Pruthi RK. Hemostatic prophylaxis and colonoscopy outcomes for patients with bleeding disorders: A retrospective cohort study and review of the literature. Haemophilia. 2020 Mar; 26 (2):257-268 Epub 2020 Mar 06
    View PubMed
  8. McBane RD 2nd, Loprinzi CL, Ashrani A, Lenz CJ, Houghton D, Zemla T, Le-Rademacher JG, Wysokinski WE. Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial. Eur J Haematol. 2020 Feb; 104 (2):88-96 Epub 2019 Nov 11
    View PubMed
  9. McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, Zemla T, Ashrani A, Tafur A, Perepu U, Anderson D, Gundabolu K, Kuzma C, Perez Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Houghton DE, Vishnu P, Loprinzi CL. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020 Feb; 18 (2):411-421 Epub 2019 Nov 28
    View PubMed
  10. Cisak KI, Macedo TA, Sheedy SP, Kamath PS, Ashrani AA. Portal Hypertensive Cholangiopathy, Which Masquerades as an Acute Portal Vein Thrombosis Journal of Diagnostic Medical Sonography. 2019.
  11. Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, Marshall AL, Hogan W, Litzow M, Hoyer J, Oliveira JL, Vishnu P, Call TG, Al-Kali A, Patnaik M, Gangat N, Pardanani A, Tefferi A, Go RS. Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clin Proc. 2019 Aug; 94 (8):1542-1550
    View PubMed
  12. Bott-Kitslaar DM, McBane RD, Casanegra AI, Houghton DE, Froehling DA, Vlazny DT, Ashrani AA, Hodge DO, Vargas ER, Bartlett MA, Saadiq RA, Daniels PR, Shields RC, Lenz CJ, Lang TR, Wysokinski WE. Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism. Mayo Clin Proc. 2019 Jul; 94 (7):1242-1252 Epub 2019 Feb 06
    View PubMed
  13. Hoversten KP, Higgins AS, Ashrani AA. 47-Year-Old Man With Pancytopenia and Fever. Mayo Clin Proc. 2019 Jun; 94 (6):1073-1078
    View PubMed
  14. Sridharan M, Fylling KA, Ashrani AA, Chen D, Marshall AL, Hook CC, Cardel LK, Nichols WL, Pruthi RK. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience. Thromb Res. 2018 Nov; 171:14-21 Epub 2018 Sept 05
    View PubMed
  15. Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018 Nov; 16 (11):1289-1303
    View PubMed
  16. Petterson TM, Smith CY, Emerson JA, Bailey KR, Ashrani AA, Heit JA, Leibson CL. Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes. Thromb Haemost. 2018 Jul; 118 (7):1316-1328 Epub 2018 July 02
    View PubMed
  17. Kaur D, Ashrani AA, Pruthi R, Khan SP, Bailey K, Rodriguez V. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT). Thromb Res. 2018 Jul; 167:44-49 Epub 2018 Apr 26
    View PubMed
  18. Goyal G, Bartley AC, Funni S, Inselman J, Shah ND, Marshall AL, Ashrani AA, Kapoor P, Durani U, Hashmi SK, Siddiqui MA, Buadi FK, Go RS, Kyle RA, Kumar S, Gonsalves WI. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia. 2018 Jun; 32 (6):1414-1420 Epub 2018 Mar 21
    View PubMed
  19. Cohoon KP, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study. Am J Med. 2018 Mar; 131 (3):307-316.e2 Epub 2017 Oct 04
    View PubMed
  20. Alsammak MS, Ashrani AA, Winters JL, Pruthi RK. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency. J Clin Apher. 2017 Dec; 32 (6):429-436 Epub 2017 Mar 15
    View PubMed
  21. Marshall AL, Perez Botero J, Botero JP, Ashrani AA, Pruthi RK, Heit JA, Chintakuntlawar A, Guenther JC, Patnaik MM. The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making. J Womens Health (Larchmt). 2017 Dec; 26 (12):1350-1355 Epub 2017 Sept 21
    View PubMed
  22. McBane RD, McBane Ii R, Loprinzi CL, Ashrani A, Perez-Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Le-Rademacher JG, Wysokinski WE. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial. Thromb Haemost. 2017 Oct 5; 117 (10):1952-1961 Epub 2017 Aug 24
    View PubMed
  23. Park MS, Spears GM, Bailey KR, Xue A, Ferrara MJ, Headlee A, Dhillon SK, Jenkins DH, Zietlow SP, Harmsen WS, Ashrani AA, Heit JA. Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: A prospective cohort study. J Trauma Acute Care Surg. 2017 Sep; 83 (3):381-387
    View PubMed
  24. Marshall AL, Durani U, Bartley A, Hagen CE, Ashrani A, Rose C, Go RS, Pruthi RK. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017 Sep; 217 (3):344.e1-344.e6 Epub 2017 May 11
    View PubMed
  25. Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood. 2017 Jul 13; 130 (2):109-114 Epub 2017 May 08
    View PubMed
  26. Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis. Vasc Med. 2017 Apr; 22 (2):121-127 Epub 2017 Mar 20
    View PubMed
  27. Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost. 2017 Jan 26; 117 (2):390-400 Epub 2016 Dec 15
    View PubMed
  28. Rugeri L, Ashrani AA, Nichols WL, Trousdale RT, Pruthi RK. A single-centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature. Haemophilia. 2016 Nov; 22: (6)934-942.
    View PubMed
  29. Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, Hashmi SK, Marshall AL, Ashrani AA, Dispenzieri A, Kyle RA, Rajkumar SV, Go RS. Prevalence, incidence and survival of smoldering multiple myeloma in the United States. Blood Cancer J 2016 Oct 21; 6 (10):e486
    View PubMed
  30. Partain DK, Botero JP, Shi M, Poterucha JJ, Ashrani AA, Thompson CA. Spur cell anemia in the setting of progressive liver allograft failure. Am J Hematol. 2016 Oct; 91 (10):1061 Epub 2016 Mar 22
    View PubMed
  31. Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thome SD, Hook CC, Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clin Proc. 2016 Sep; 91 (9):1189-211 Epub 2016 Aug 03
    View PubMed
  32. Cohoon KP, Ransom JE, Leibson CL, Ashrani AA, Petterson TM, Long KH, Bailey KR, Heit JA. Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study. Am J Med. 2016 Sep; 129 (9):1000.e15-25 Epub 2016 Mar 21
    View PubMed
  33. Park MS, Perkins SE, Spears GM, Ashrani AA, Leibson CL, Boos CM, Harmsen WS, Jenkins DH, Bailey KR, Ballman KV, Heit JA. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study. Thromb Res. 2016 Aug; 144:40-5 Epub 2016 Mar 29
    View PubMed
  34. Bott-Kitslaar DM, Saadiq RA, McBane RD, Loprinzi CL, Ashrani AA, Ransone TR, Wolfgram AA, Berentsen MM, Wysokinski WE. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry. Am J Med. 2016 Jun; 129 (6):615-9 Epub 2016 Jan 18
    View PubMed
  35. Perez Botero J, Ormsby WD, Ashrani AA, McBane RD 2nd, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. Eur J Intern Med. 2016 May; 30:77-81.
    View PubMed
  36. Ashrani AA, Gullerud RE, Petterson TM, Marks RS, Bailey KR, Heit JA. Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res. 2016 Mar; 139:29-37. Epub 2016 Jan 05.
    View PubMed
  37. Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw. 2015 Sep; 13 (9):1079-95
    View PubMed
  38. Ashrani AA. Pulmonary Infarction Manifesting as a Cavitary Lesion. Mayo Clin Proc. 2015 Aug; 90: (8)1170.
    View PubMed
  39. Heit JA, Lahr BD, Ashrani AA, Petterson TM, Bailey KR. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015 Aug; 136 (2):298-307 Epub 2015 June 24
    View PubMed
  40. Ashrani AA, Barsoum MK, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Thromb Res. 2015 Jun; 135 (6):1110-6 Epub 2015 Apr 11
    View PubMed
  41. Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Petterson TM, Long KH, Bailey KR, Heit JA. Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care. 2015 Apr 1; 21 (4):e255-63 Epub 2015 Apr 01
    View PubMed
  42. Petterson TM, Marks RS, Ashrani AA, Bailey KR, Heit JA. Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res. 2015 Mar; 135 (3):472-8 Epub 2014 Dec 16
    View PubMed
  43. Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Park MS, Petterson TM, Long KH, Bailey KR, Heit JA. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery. 2015 Mar; 157 (3):423-31 Epub 2015 Jan 26
    View PubMed
  44. Barbara DW, McKenzie KM, Parikh SA, Ashrani AA, Pruthi RK, Burkhart HM, Suri RM, Mauermann WJ. Successful Perioperative Management of Severe Bleeding From Undiagnosed Acquired Factor VIII Inhibitors. J Cardiothorac Vasc Anesth. 2015; 29: (3)731-4.
    View PubMed
  45. Perez Botero J, Spoon DB, Patnaik MS, Ashrani AA, Trousdale RT, Pruthi RK. Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study. Thromb Res. 2015 Jan; 135(1):109-13. Epub 2014 Nov 18.
    View PubMed
  46. Gatt A, Chen D, Pruthi RK, Kamath PS, Leise MD, Ashrani AA, Nichols WL, He R. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective. Semin Thromb Hemost. 2014 Nov; 40(8):845-51. Epub 2014 Nov 13.
    View PubMed
  47. Leibson CL, Petterson TM, Smith CY, Bailey KR, Emerson JA, Ashrani AA, Takahashi PY, Heit JA. Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest. 2014 Aug; 146 (2):412-421
    View PubMed
  48. Chee CE, Ashrani AA, Marks RS, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood. 2014 Jun 19; 123 (25):3972-8 Epub 2014 Apr 29
    View PubMed
  49. Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, Specks U. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):301-10.
    View PubMed
  50. Froehling DA, Daniels PR, Mauck KF, Collazo-Clavell ML, Ashrani AA, Sarr MG, Petterson TM, Heit JA. Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study. Obes Surg. 2013 Nov; 23(11):1874-9.
    View PubMed
  51. Mauck KF, Froehling DA, Daniels PR, Dahm DL, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. J Thromb Haemost. 2013 Jul; 11 (7):1279-86
    View PubMed
  52. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma. 2013 Jun; 54 (6):1263-7 Epub 2012 Nov 19
    View PubMed
  53. Leibson CL, Petterson TM, Smith CY, Bailey KR, Ashrani AA, Heit JA. Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc. 2012 Sep; 60 (9):1718-23 Epub 2012 Aug 06
    View PubMed
  54. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook C, Kaufmann SH, Pruthi RK, Pardanani A, Begna KH, Ashrani AA, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy. Eur J Haematol. 2012 Mar; 88(3):237-43. Epub 2011 Nov 17.
    View PubMed
  55. Heit JA, Lahr BD, Petterson TM, Bailey KR, Ashrani AA, Melton LJ 3rd. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood. 2011 Nov 3; 118 (18):4992-9 Epub 2011 Sept 02
    View PubMed
  56. Sumekar TA, Ashrani AA, Winarni TI, Hagerman RJ. Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. Case Reports in Genetics. 2011.
  57. Tafur AJ, Kalsi H, Wysokinski WE, McBane RD, Ashrani AA, Marks RS, Crusan DJ, Petterson TM, Bailey KR, Heit JA. The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc. 2011 Jan; 86 (1):25-30
    View PubMed
  58. Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010 Nov; 126 (5):373-8 Epub 2010 Sept 15
    View PubMed
  59. Ashrani AA, Silverstein MD, Rooke TW, Lahr BD, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study. Vasc Med. 2010 Oct; 15 (5):387-97
    View PubMed
  60. Naina HV, Patnaik MM, Ali UA, Chen D, Ashrani AA. Systemic fibrinolysis caused by tissue plasminogen activator-producing metastatic breast cancer. J Clin Oncol. 2010 Apr 10; 28(11):e167-8. Epub 2010 Jan 11.
    View PubMed
  61. Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009 Nov; 28 (4):465-76 Epub 2009 Feb 18
    View PubMed
  62. Ashrani AA, Silverstein MD, Lahr BD, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med. 2009 Nov; 14 (4):339-49
    View PubMed
  63. Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ 3rd. Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol. 2009 Sep; 29 (9):1399-405 Epub 2009 June 18
    View PubMed
  64. Ashrani AA, Rajkumar SV. Chemotherapy-associated thrombosis. Cancer Treat Res. 2009; 148:181-206.
    View PubMed
  65. Ashrani AA, Heit JA. Risk factors for thrombosis in cancer patients. Cancer Treat Res. 2009; 148:95-114.
    View PubMed
  66. Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S, Universal Data Collection Project Investigators. Septic arthritis in males with haemophilia. Haemophilia. 2008 May; 14 (3):494-503 Epub 2008 Feb 21
    View PubMed
  67. Ashrani AA, Reding MT, Shet A, Osip J, Humar A, Lake JR, Key NS. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor. Haemophilia. 2004 Nov; 10(6):735-7.
    View PubMed
  68. Ashrani AA, Osip J, Christie B, Key NS. Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre. Haemophilia. 2003 Nov; 9(6):721-6.
    View PubMed
  69. Ashrani AA, Aysola A, Al-Khatib H, Nichols WL, Key NS. Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol. 2003 May; 121(4):639-42.
    View PubMed
  70. Bloom SH, Coad JE, Greeno EW, Ashrani AA, Hammerschmidt DE. Cholecystitis as the presenting manifestation of acute myeloid leukemia: report of a case. Am J Hematol. 2002 Jul; 70(3):254-6.
    View PubMed
  71. Ashrani AA, Reding MT, Greeno EW, Shet A, Key NS. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia. Haemophilia. 2002 Jan; 8(1):56-8.
    View PubMed
  72. Ashrani A, Keshavarzian A, Jacyno M, Winship D, Fields JZ. Are dipyridamole (sensitive) calcium channels present in esophageal smooth muscle? Life Sci. 1997; 60(26):PL423-30.
    View PubMed